SherpaBonds
US78081BAK98 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 2.20% 2030/09

Royalty Pharma PlcUnited StatesGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
90.81
par = 100
YIELD TO MAT.
4.68%
semi-annual
COUPON
2.200%
semi-annual · fixed
MATURITY
2030-09-02
bullet · 4.31y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
4.02 y
1bp ↑ ≈ -0.040% P&L
Convexity
18.62
higher = more curvature
Years to maturity
4.31 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
Vanguard Short-Term Corporate Bond
Vanguard
US Corporate Short$21.6M—0.04%2026-03-31
Vanguard Intermediate-Term Corporate Bond
Vanguard
US Corporate Intermediate$19.2M—0.03%2026-03-31
Vanguard Total Bond Market
Vanguard
US Aggregate$15.4M—0.00%2026-03-31
Vanguard Intermediate-Term Bond
Vanguard
US Aggregate Intermediate$6.3M—0.01%2026-03-31
Invesco BulletShares 2030 Corporate Bond
Invesco
BulletShares 2030 Corporate$6.0M▲ $5K0.24%2026-05-05
iShares iBoxx $ Investment Grade Corporate Bond
iShares
US IG Corporate$6.0M▼ $12K0.02%2026-05-07
iShares 1-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate 1-5Y$5.6M▼ $6K0.03%2026-05-07
Vanguard Short-Term Bond
Vanguard
US Aggregate Short$4.9M—0.01%2026-03-31
iShares iBonds Dec 2030 Term Corporate
iShares
iBonds 2030 Corporate$4.7M▼ $5K0.15%2026-05-07
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$4.1M▼ $5K0.00%2026-05-07
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$1.9M▼ $2K0.01%2026-05-07
iShares Systematic Bond
iShares
US Multi-Sector$1.6M▼ $2K0.16%2026-05-07
SPDR Portfolio Intermediate Term Corporate Bond
SPDR
US IG Corporate Intermediate$1.5M▲ $2K0.01%2026-05-05
iShares Core Universal USD Bond
iShares
US Aggregate$949K▼ $1K0.00%2026-05-07
iShares 0-5 Year Investment Grade Corporate Bond
iShares
US IG Corporate$644K▼ $1K0.03%2026-05-07
SPDR Portfolio Corporate Bond
SPDR
US IG Corporate$577K▲ $7420.03%2026-05-05
iShares Core 1-5 Year USD Bond
iShares
US Short-Term Core$395K▼ $4440.01%2026-05-07
iShares ESG Aware 1-5 Year USD Corporate Bond
iShares
US IG Corporate ESG$331K▼ $3730.03%2026-05-07
iShares Intermediate Government/Credit Bond
iShares
US Govt/Credit$209K▼ $2350.01%2026-05-07
SPDR Portfolio Aggregate Bond
SPDR
US Aggregate$192K▲ $2470.00%2026-05-05
iShares Interest Rate Hedged Corporate Bond
iShares
US IR Hedged IG Corporate$97K▼ $9270.02%2026-05-07
iShares ESG Advanced Universal USD Bond
iShares
US Aggregate$45K▼ $510.01%2026-05-07
iShares iBonds 1-5 Year Corporate Ladder
iShares
iBonds Corporate$23K—0.03%2026-05-06
iShares Inflation Hedged Corporate Bond
iShares
US IG Corporate$13K▼ $1280.02%2026-05-07
iShares Government/Credit Bond
iShares
US Govt/Credit$9K▼ $100.01%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

52/ 100Active coverage
Interpretation. Moderate institutional footprint, with net distribution
HOLDERS
26
▲ 5 signals in 7d
AGGREGATE EXPOSURE
$102.3M
USD across all
TOP CONCENTRATION
21.2%
largest holder
FLOW
▼ $4.5M
▲ 5 signals in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
90,814 USD
PRICE
90.81

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 2.2 09/02/30
FIGI
BBG011Q51G09
CUSIP
78081BAK9
ISIN
US78081BAK98
Type
Corp
Issued
2021-03-02
Face value
100 USD
Ticker
RPRX 2.2 09/02/30
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 4.45% 03/2031
Royalty Pharma Plc
2031-03
4.71%
+3 bps yield+7mo duration8 signals in commonSame issuer
Royalty Pharma Plc 5.15% 09/2029
Royalty Pharma Plc
2029-09
4.60%
−8 bps yield−1y duration9 signals in commonSame issuer
Royalty Pharma Plc 2.15% 09/2031
Royalty Pharma Plc
2031-09
4.78%
+10 bps yield+1y duration6 signals in commonSame issuer
Royalty Pharma Plc 1.75% 09/2027
Royalty Pharma Plc
2027-09
4.44%
−24 bps yield−3y duration9 signals in commonSame issuer
Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
+60 bps yield+5y duration9 signals in commonSame issuer
Royalty Pharma Plc 5.4% 09/2034
Royalty Pharma Plc
2034-09
5.19%
+51 bps yield+4y duration5 signals in commonSame issuer